Sunshine Biopharma (SBFM) Total Current Liabilities (2016 - 2025)
Historic Total Current Liabilities for Sunshine Biopharma (SBFM) over the last 11 years, with Q3 2025 value amounting to $6.7 million.
- Sunshine Biopharma's Total Current Liabilities rose 4687.75% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 4687.75%. This contributed to the annual value of $6.3 million for FY2024, which is 1374.46% up from last year.
- Sunshine Biopharma's Total Current Liabilities amounted to $6.7 million in Q3 2025, which was up 4687.75% from $5.6 million recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's Total Current Liabilities registered a high of $6.9 million during Q4 2022, and its lowest value of $91229.0 during Q4 2021.
- Its 5-year average for Total Current Liabilities is $3.8 million, with a median of $5.1 million in 2023.
- Its Total Current Liabilities has fluctuated over the past 5 years, first tumbled by 9132.23% in 2021, then surged by 749738.02% in 2022.
- Sunshine Biopharma's Total Current Liabilities (Quarter) stood at $91229.0 in 2021, then skyrocketed by 7497.38% to $6.9 million in 2022, then dropped by 19.9% to $5.6 million in 2023, then increased by 13.74% to $6.3 million in 2024, then grew by 5.33% to $6.7 million in 2025.
- Its last three reported values are $6.7 million in Q3 2025, $5.6 million for Q2 2025, and $5.8 million during Q1 2025.